DOI:
10.1055/s-00000133
Gastroenterologie up2date
LinksClose Window
References
Allegra CJ, Yothers G, O’Connell MJ. et al.
Initial safety report of NSABP C-08: a randomized phase III study of modified FOLFOX6 with or without bevacizumab for the adjuvant treatment of patients with stage II or III colon cancer.
J Clin Oncol 2009; 27: 3385-3390
Search in:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.